Orexo AB To Discuss The Commercialization Plans For The Digital Therapies Call Transcript
Hello and welcome to the Orexo press conference. (Operator Instructions)
Today, I'm pleased to present Nikolaj Sørensen and Dennis Urbaniak, EVP Digital Therapeutics. Please begin your meeting.
¸ - ()-&
Thank you very much, and thank you for those of you who are dialing in, and those of you who are following online. This is a fantastic day for Orexo and something that we have been working more or less around the clock for -- during the last few months.
As we have previously announced, we have acquired the rights to several digital therapies in the (inaudible), we were suddenly faced by the COVID-19 epidemic, which was both forcing us to change our operating model and preparation model, but it also gave us an opportunity to accelerate the launch of the products compared to the original plans, which were in late Q3 for vorvida and for deprexis and for OXD01, the plan was to launch that product in 2022. Now we have been able to advance
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
